Z17.41
Hormone receptor positive
Clinical Classification Guidelines
Inclusion Terms
- HR+
Medical Intelligence & Overview
The ICD-10 code Z17.41 refers to a diagnosis of hormone receptor positive status, commonly associated with certain types of cancer, particularly breast cancer. When a tumor is hormone receptor positive (HR+), it means that the cancer cells have receptors for hormones like estrogen or progesterone. These hormones can promote the growth of the cancer. Identifying HR+ status helps in guiding treatment strategies and understanding the prognosis. This diagnosis is critical in the realm of personalized medicine, as it influences decisions around hormone therapy and other targeted treatments.
Causes & Symptoms
Clinical Causes: Genetic mutations that lead to overexpression of hormone receptors on tumor cells Hormonal imbalances that promote receptor activity Environmental factors influencing hormone levels Family history of hormone receptor-positive cancers Previous exposure to radiation or certain carcinogens
Key Symptoms: Lump or thickening in the breast tissue Changes in the size, shape, or appearance of the breast Unexplained nipple discharge, other than breast milk Skin dimpling or puckering on the breast Persistent pain in the breast or nipple area Swelling or redness around the breast
Diagnostic & Treatment
Diagnosis Path: Diagnosis of hormone receptor positive status involves several steps:
Treatment Protocols: Treatment options for hormone receptor positive cancer primarily focus on hormone therapy, often combined with other modalities:
Clinical Advice & FAQs
Billing Guidance
Is Z17.41 a billable ICD-10 code?
Yes, Z17.41 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report Z17.41?
Clinical documentation must specify the nature of Hormone receptor positive and any associated comorbidities for accurate reporting.
Cite this Clinical Reference